Abstract
Background: The aim of the present study was to determine serum and follicular fluid C-reactive protein (CRP) levels in patients undergoing controlled ovarian hyperstimulation (COH) for IVF-embryo transfer cycle, and their possible correlation to COH variables. Patients and Methods: The subjects were 16 consecutive patients undergoing our routine IVF long GnRH agonist protocol. Blood was drawn three times during the COH cycle: (i) the day on which adequate suppression was obtained (Day-S); (ii) the day of, or prior to HCG administration (Day-HCG); and (iii) the day of (and before) oocyte pick-up (Day-OPU). Levels of sex steroids and serum and follicular fluid CRP were compared among the three time points. Serum and follicular fluid CRP were measured with a commercial immunoturbidimetric assay. Results: Serum levels of CRP were significantly higher on Day-OPU and Day-HCG than on Day-S, and significantly higher on Day-OPU than on Day-HCG. No difference was observed between follicular and serum CRP levels on Day-OPU. No significant correlations were found between serum and follicular fluid CRP, or between serum CRP-to-BMI ratio and serum sex steroid levels or IVF treatment variables. Conclusions: The significant increase in serum CRP levels during COH, especially after HCG administration, suggests that COH potentiates a state of systemic inflammation.
| Original language | English |
|---|---|
| Pages (from-to) | 357-359 |
| Number of pages | 3 |
| Journal | Human Reproduction |
| Volume | 19 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1 Jan 2004 |
| Externally published | Yes |
Keywords
- BMI
- C-reactive protein
- Follicular fluid
- Ovulation induction
- Sex steroids
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology
Fingerprint
Dive into the research topics of 'C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation of IVF cycle'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver